Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1399.3000 -41.70 (-2.89%)
NSE Sep 22, 2025 15:31 PM
Volume: 222.7K
 

1399.30
-2.89%
Sharekhan
Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations.
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories…
All earning calls
Investor presentations from Ipca Laboratories…
All investor presentations